Impax Asset Management Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,375,396
Closed -$32.3M 396
2023
Q1
$32.3M Sell
1,375,396
-181,795
-12% -$4.88M 0.14% 117
2022
Q4
$43.5M Buy
1,557,191
+749,215
+93% +$19.2M 0.19% 107
2022
Q3
$18.9M Buy
807,976
+272,706
+51% +$8.23M 0.1% 119
2022
Q2
$18.1M Sell
535,270
-188,312
-26% -$6.6M 0.09% 124
2022
Q1
$25.3M Sell
723,582
-187,222
-21% -$6.4M 0.1% 114
2021
Q4
$27.7M Buy
910,804
+190,559
+26% +$6.21M 0.1% 111
2021
Q3
$23.6M Buy
720,245
+266,000
+59% +$8.51M 0.1% 110
2021
Q2
$13.7M Buy
+454,245
New +$15M 0.06% 128

Other funds holding OGN

Impax Asset Management Group's OGN Position: Q2 2023 in Review

Impax Asset Management Group sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 1,375,396 shares — an estimated $32.3M sold.

Impax Asset Management Group first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $43.5M in Q4 2022. 727 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Impax Asset Management Group reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Impax Asset Management Group sold 1,375,396 Organon & Co shares in Q2 2023, an estimated $32.3M.
  • Impax Asset Management Group first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • Impax Asset Management Group's Organon & Co position peaked at $43.5M in Q4 2022.
  • 727 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Impax Asset Management Group's 13F filing for Q2 2023, filed 7 Aug 2023.